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Abstract
Purpose To estimate global rates of glaucoma surgery.
Methods National glaucoma and national ophthalmology so-
cieties were contacted to obtain rates of glaucoma surgery for
the preceding 5 years. In countries without a professional
society, leading ophthalmologists or non-governmental orga-
nizations (NGO) were approached.When available, published
literature was used for the estimates. Three levels of evidence
were assigned: published data from central government or
insurance registries (level I), estimates provided by a national
professional society based on survey of members (level II),
and estimates based on data from individual glaucoma sur-
geons (level III). Glaucoma surgical rate (GSR) was defined
as the annual number of total glaucoma surgeries performed
per million population. Linear regression analysis was
performed between GSR and the following parameters: pop-
ulation per ophthalmologist, per capita gross domestic product
(GDP), and per capita health expenditures.
Results Seventy-three glaucoma societies, 35 ophthalmology
societies, as well as six NGOs and 37 leading ophthalmolo-
gists (11 other countries) were contacted. Data were obtained
from 38 countries (10 level I, 23 level II, and 5 lev el III) with a
total population of 1.723 billion. The average GSR was 139.2
±113.1 (range, 2.9–500.0). There was a positive correlation
between GSR and GDP (r2=0.309, P=0.0004) and GSR and
the number of ophthalmologists (r2=0.476, P <0.0001).
Conclusion There is a paucity of data on rates of glaucoma
surgery, particularly from developing countries. The new met-
ric GSR may be useful for the allocation of healthcare re-
sources, as well as for planning and monitoring public health
interventions in glaucoma.
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Introduction
Glaucoma is the leading cause of irreversible blindness world-
wide [1]. Although elevated intraocular pressure (IOP) is no
longer considered to be a defining feature of the disease, it is
still recognized as a major risk factor, and remains the only
modifiable one [2]. The three treatment modalities by which
IOP is lowered are medical therapy, laser intervention, and
surgery. Despite the recognition of glaucoma as a public
health problem by the World Health Organization (WHO)
[3], its inclusion in subsequent 5-year plans of the VI-
SION2020 Prevention of Blindness initiative has been
prevented due to complexities in diagnosis [4] and treatment
[5, 6]. Paucity of epidemiological data in glaucoma poses an
additional challenge for the formulation of public health
strategies.
The number of glaucoma surgeries performed worldwide is
not known. A Medline search of published literature yielded
only six countries with available data [7–12]. No published
data were available from any developing country. This lack of
data is significant for two reasons. First, the prevalence of
glaucoma-related blindness is mostly at its highest in older
populations who live in developing countries [3]. Second,
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some investigators argue that, from a cost perspective, the
adequate approach to tackle the glaucoma burden on the
health systems of developing countries may be through
surgery [5, 13].
Understanding trends and patterns in glaucoma manage-
ment is of critical importance for clinicians, researchers, and
policy-makers alike. In settings of low or reduced health care
budgets, decision-makers increasingly determine the alloca-
tion of funds based on the availability of epidemiological data.
Therefore, in the absence of global data on provision and
uptake of glaucoma services, the needs of glaucoma patients
are at risk of being further underestimated and unaddressed.
Despite this need, no data on the global rates of glaucoma
surgery are currently available. In this study, we expand the
available knowledge on the worldwide numbers of glaucoma
surgery (including cyclodestructive procedures) through a
survey of national glaucoma and ophthalmological societies.
Methods
A list of 73 member national glaucoma societies was request-
ed and provided by the secretariat of the World Glaucoma
Association on January 6th, 2011. For countries without a
national glaucoma society, the national ophthalmological so-
ciety or national prevention of blindness committees (n =35)
were identified through the database of the International
Council of Ophthalmology (http://www.icoph.org/
advancing_leadership/ophthalmologic_societies.html; last
accessed June 4, 2011). For all other countries, non-
governmental organizations (NGOs) and leading ophthalmol-
ogists were identified through conference participation lists
and the authors’ personal database. All contacts were
contacted by email. Three attempts were made in each case.
If addressees failed to respond, the particular country was
recorded as “no response”. When members’ email addresses
were expired or incorrect, they were contacted by mail (n =4).
In the survey, we sought to obtain the total number of glau-
coma surgeries between 2006 and 2010, stratified by type of
glaucoma surgery [trabeculectomy, non-penetrating glaucoma
surgery; combined filtering and cataract surgery; glaucoma
drainage device (GDD)/tubes/valves; cyclodestructive proce-
dures; and others (including more recent surgical proce-
dures)]. Three levels of evidence were assigned. A level I
rating was assigned to published epidemiological literature
or data from central government and/or insurance registries.
A level II rating was assigned to estimates provided by na-
tional professional societies based on a member survey, and a
level III classification was applied to estimates provided by
key ophthalmology leaders based on data emanating from
individual institutions.
Population size and structure are based on the ‘World
Population Prospects: the 2008 Revision’ from the United
Nations Population Division [14]. Data on per capita health
expenditure were obtained from theWorld Bank (World Bank,
World Development Indicators. www.worldbank.org.
Accessed on April 11, 2011). Data on per capita Gross
Domestic Product (GDP) were obtained from the International
Monetary Fund (IMF) (World Economic Outlook Database-
April 2011, International Monetary Fund. www.imf.org.
Accessed on April 11, 2011). For ease of comparison with
other global epidemiological surveys, countries were grouped
according to WHO regions: African region (AFR), region of
the Americas (AMR), Eastern Mediterranean region (EMR),
European region (EUR), South-east Asian region (SEAR),
and Western Pacific region (WPR) [15].
For ease of comparison, we developed a new metric, the
glaucoma surgical rate (GSR). GSR was defined as the annual
number of total glaucoma surgeries performed per million
population. Linear regression analysis was performed to eval-
uate the correlation between GSR to the number of population
per ophthalmologist, GDP per capita (USD), and total health
expenditure per capita (USD). For this analysis, both the
dependent (GSR) and the predictor variable were log-
transformed to correct for skewed data. Statistical analyses
were performed using Stata 10.0 (StataCorp, College Station,
TX, USA).
Results
In total, 73 national glaucoma societies and 35 national oph-
thalmological societies were contacted. For 11 other countries
without any official professional organization, six NGOs and
37 leading ophthalmologists were contacted. The response
rate was 71.2 % for national glaucoma societies, 60.0 % for
national ophthalmological societies and national prevention of
blindness committees, 100 % for NGOs, and 84 % for indi-
vidually approached ophthalmologists. Data were obtained
from 38 countries in five continents covering all six WHO
regions, with a total population of 1.723 billion.
Table 1 shows the source and year of data as well as the
estimated numbers of glaucoma surgery performed in each
country. There was a wide variation in glaucoma surgical rates
both within and between regions (Fig. 1). The region with the
most data (18 countries) as well as the highest GSR was the
European region, where the GSR ranged from 500.0
(Germany) to 85.2 (Netherlands). In the region of the
Americas (eight countries), GSR ranged from 274.3 (USA)
to 31.5 (Paraguay). In the Eastern Mediterranean region (six
countries), Iran had the highest GSR (68.6) and Sudan the
lowest (30.0). In the Western Pacific region (three countries),
GSR ranged from 234.0 (Singapore) to 122.6 (South Korea).
Data were available from two countries in the African region
(Ghana, GSR 7.0 and Ivory Coast, GSR 2.9), and only one
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country in the south-east Asian region (Bangladesh, GSR
77.0).
Data from 21 countries provided a breakdown by type of
surgery. Trabeculectomy was the most frequently performed
glaucoma surgery in all 21 countries, accounting for an aver-
age 77.7 % of all glaucoma surgeries (range: Ivory Coast,
100 % to South Korea, 45.7 %). Six countries provided data
on combined filtering/cataract extraction-surgery. In these,
combined surgeries accounted for an average 9.7 % of all
surgeries (range: Ghana, Latvia, Sudan, Tunisia, 0 % to Sin-
gapore, 47.0 %) In eight countries, in which data on non-
penetrating glaucoma surgery (NPGS) were available, NPGS
Table 1 Sources of information for data on glaucoma surgical rates, by World Health Organization region
WHO region Country Source of data Evidence
level
Year Number of
glaucoma surgeries
GSR
(sx/mill/year)
AFR Ghana MoH/NPBC II 2010 167 7.0
Ivory Coast NPBC III 2010 60 2.9
AMR Bolivia Glaucoma society II 2010 286 29.0
Brazil Ophthalmologists III 2010 3,286 16.9
Canada Published literature [11, 16] I 2004 5,870 174.0
Chile Glaucoma society II 2010 1,750 103.0
Colombia Glaucoma society II 2010 2,900 63.5
Paraguay Glaucoma society II 2010 200 31.5
Puerto Rico Glaucoma society II 2010 171 43.1
USA Published literature [7] I 2006 84,220 274.3
EMR Iran Ophthalmologists III 2010 4,926 68.6
Kuwait Ophthalmologists III 2010 150 53.7
Oman MoH I 2010 102 35.9
Pakistan Glaucoma society II 2010 10,000 58.9
Sudan Glaucoma society II 2010 1,268 30.0
Tunisia NPBC II 2010 500 47.9
EUR Azerbaijan Glaucoma society II 2010 994 113.2
Belgium Insurance database I 2010 1,556 144.2
France Published literature [9] I 2000 22,890 365.6
Georgia Glaucoma society II 2010 955 97.2
Germany Glaucoma society II 2009 37,500 500.0
Israel Glaucoma society II 2010 1,299 148.9
Netherlands Published literature [10] I 2003 1,408 85.2
Norway Glaucoma society II 2010 739 153.1
Latvia Glaucoma society II 2010 563 250.0
Lithuania Glaucoma society II 2010 1,095 365.0
Poland Glaucoma society II 2010 6,500 170.4
Portugal Glaucoma society I 2010 1,124 105.7
Romania Glaucoma society II 2010 3,500 162.9
Russia Glaucoma society II 2010 40,000 282.2
Serbia Glaucoma society II 2010 676 92.4
Slovenia Glaucoma society II 2010 210 105.0
UK Published literature [12, 17] I 2004 7,191 132.4
Ukraine MoH II 2010 13,700 297.8
SEAR Bangladesh Glaucoma society II 2010 12,492 77.0
WPR Australia Published literature [8] I 2003 4,010 183.3
Singapore Ophthalmologists III 2010 1,167 234.0
South Korea Insurance database I 2010 5,974 122.6
AFR African region, AMR region of the Americas, EMR Eastern Mediterranean region, EUR European region, Ophthalmologists Leading ophthal-
mologists,MoH Ministry of Health, NPBC National Prevention of Blindness Committee, SEAR South-East Asian region, Sx surgeries,WPR Western
Pacific region
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constituted on average 6.6 % (range: Ghana, 0 % to Georgia,
20.0 %) of all glaucoma surgeries. Use of GDDs/tubes/valves
accounted for an average of 8.9 % of all glaucoma surgeries in
the 19 countries that had data on their use (range: Ivory Coast,
Lithuania, 0 % to Puerto Rico, 36.3 %). Fifteen countries
provided data on cyclodestructive procedures. These proce-
dures constituted 7.8 % of all glaucoma surgeries (range:
Bolivia, Chile, Ivory Coast, Ghana, Latvia, Puerto Rico,
Tunisia, 0 % to Lithuania 21.9 %).
Using population data, we calculated the number of popu-
lation per ophthalmologist. The mean number of people per
ophthalmologist was 64,452 (median, 25,303,7; interquartile
range, 27,316.8), with a minimum of 8,571 (Lithuania) and a
maximum of 496,609 (Ghana) people per ophthalmologist.
When GSR was plotted against the number of population per
ophthalmologist based on the log-transformed model, a strong
negative correlation (r 2=0.476, P <0.0001) was found
(Fig. 2). After excluding the four countries (Ghana, Ivory
Coast, Sudan, and Bangladesh) with a population/
ophthalmologist ratio above 100,000, this correlation became
weaker (r2=0.208, P=0.010). There was also a positive cor-
relation between per capita GDP and GSR (r2=0.309, P=
0.0004) after log-transformation (Fig. 3). A positive correla-
tion was also found between total per capita health care
expenditure and GSR (r 2=0.418, P <0.0001) after log-
transformation (Fig. 4).
Discussion
The current study estimates global numbers of glaucoma
surgery. Despite dedicated efforts from the study investigators
and the contacted national glaucoma and ophthalmological
societies, data were only available from 38 countries, with
only six of them accessible to the scientific community via
Medline.
A series of epidemiological studies and landmark glauco-
ma trials conducted in the past decade have led to better
understanding of the global burden of glaucoma [3] and its
treatment [18]. While the former enable a worldwide
Fig. 1 Overview of glaucoma
surgical rates (GSR) by country.
Vertical lines indicate mean
(continuous line) and median
GSR (interrupted line)
Fig. 2 a ,b Scatterplot showing
correlation of glaucoma surgical
rates and number of population
per ophthalmologist in absolute
numbers (a , left) and after log
transformation of both variables
(b , right). Lines represent linear
correlation (continuous line)
and LOWESS smoothing
(b , interrupted line)
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cartography of the prevalence of glaucoma, the latter provide
evidence that IOP-lowering reduces the risk for the onset and
progression of glaucoma. However, little is known about the
numbers of glaucoma surgery performed worldwide, with the
exception of a few developed countries.
There may have been a decline of surgical rates starting in
the mid-nineties with the introduction of two new classes of
topical glaucoma medications and new combination eye
drops. In France, Baudouin et al. [9] found a decrease of
47 % in the number of glaucoma surgical procedures between
1997 and 2000. In the same period, the number of medically
treated glaucoma cases increased from 410,000 to 734,000.
Similarly, in the Netherlands, a 45 % decline of glaucoma
surgery was registered in the same period. In Australia,
Walland [8] found a decrease of 57.6 % in trabeculectomy
rates between 1994 and 2003, and a decrease of 61.7 % from
the peak rate in 1996. Although our survey had requested
glaucoma surgical data from the preceding 5 years, only three
countries were able to provide these numbers. In Belgium,
between 1995 and 2010, the decrease in single procedure
glaucoma surgeries (from 1,961 to 1,480 interventions) was
overshadowed by a dramatic fall in combined glaucoma/
cataract procedures (from 1,243 to 76), signifying a possible
change in that country’s practice patterns. In contrast, we
found that in Bolivia the number of glaucoma surgeries in-
creased from 147 in 2006 to 286 in 2010.
Despite limited country-specific data on types of glaucoma
surgery, some conclusions can be drawn from our survey.
Trabeculectomy constituted the overwhelming majority of
glaucoma surgeries, with little uptake of NPGS, where data
were available. Despite its reported better safety profile, the
equivalence of NPGS to trabeculectomy in terms of efficacy
remains controversial [19]. In addition to the long learning
curve related to surgical skills and knowledge of the anatomy,
the wide use of NPGS is still hindered by the increased cost
related to the need for intraoperative use of space-maintainers
[20, 21] and postoperative use of laser goniopuncture [22].
With the introduction of a new metric, GSR, as the number
of glaucoma operations performed annually per million pop-
ulation, we seek to emulate the example of the cataract surgery
rate (CSR), introduced in the 1990s [23]. The CSR enabled
easy comparisons between countries and provided public
health initiatives with an easy-to-measure success criterion
[24]. Glaucoma is a chronic disease and glaucoma surgery,
unlike cataract surgery, is frequently not sufficient as a single
intervention. Consequently, it is not known what a sufficient
and sustainable GSR is and it is possible that an “ideal”
standard GSR does not exist. Campbell et al. [16], using
Canadian provincial insurance databases, estimated the num-
ber of glaucoma surgeries per 1,000 patients with glaucoma to
be 28. Using Canada with its widely accessible public health
care service as an example of an ideal situation, 2.8 surgeries
per 1,000 glaucoma patients per year could be used as a target.
Using data from a population-based prevalence study [25], we
have estimated the number of people above the age of 30 with
glaucoma to be 614,228 in Ghana and 523,329 in the Ivory
Fig. 3 a ,b Scatterplot showing
correlation of glaucoma surgical
rates and per capita gross
domestic product (2009, US$) in
absolute numbers (a , left) and
after log transformation of both
variables (b , right). Lines
represent linear correlation
(continuous line) and LOWESS
smoothing (b , interrupted line)
Fig. 4 a ,b Scatterplot showing
correlation of glaucoma surgical
rates and per capita expenditure
on health (2009, US$) in absolute
numbers (a , left) and after log
transformation of both variables
(b , right). Lines represent linear
correlation (continuous line) and
LOWESS smoothing (b ,
interrupted line)
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Coast in the year 2010 (unpublished data). These data were
then used to project the target number of glaucoma surgeries
as a function of the estimated 2010 population with glaucoma.
Assuming a similar health care scenario as in Canada, 1,719.8
and 1,465.3 annual glaucoma surgeries would be necessary in
Ghana and Ivory Coast respectively. This would correspond to
a target GSR of 72.1 for Ghana and 69.5 for Ivory Coast,
respectively, or a 10- (Ghana) and 24-fold (Ivory Coast)
increase of the current GSR. This target GSR is, of course, a
gross simplification, given very different socio-economic
backgrounds as well as disease profiles between these West
African countries and Canada. Furthermore, previous regional
studies of glaucoma surgical rates have evaluated trends, since
rates are dynamic and affected by a variety of influences.
The present study provides the first global estimates of the
rates of glaucoma surgery. As such, it is subject to numerous
assumptions and limitations. The first is a scarcity of data.
Only 38 countries could provide data on glaucoma surgery,
with only 33 of those emanating from a survey or a central
database. These numbers compare well with initial estimates
of the global burden of blindness (based on 17 countries) [26]
and prevalence of glaucoma (based on 19 countries) [27].
Subsequent updates of these could rely on more data [28,
29]. It should be noted that data from India and China are
absent. The authors are aware of efforts to gather data in these
two countries that started as a consequence of this survey.
The issue of the reliability of data is another concern. These
comparisons are limited by our inability to verify the prove-
nance and accuracy of the obtained data. Estimates based on
data provided by leading ophthalmologists (level III evidence)
are particularly subject to bias. The dissociation of public–
private health care provision is a further limiting factor in data
collection. Countries with a strong centralized public health
system have the best access to data. Other countries have
mixed public–private health systems, which introduces uncer-
tainties in the data. In the US, for example, data were only
available from Medicare, which covers persons over the age
65 enrolled in Medicare fee for service, excluding younger
patients, some privately insured patients, and patients receiv-
ing care from the US Veteran’s Administration health care
system. Finally, the new metric itself is limited by the use of
the total population as the denominator. Using the population
with glaucoma would have provided a more targeted metric.
However, due to lack of data on glaucoma prevalence in many
populations, this approach would have introduced an addi-
tional level of uncertainty into the metric.
Despite these limitations, our results provide a useful over-
view of the global rates of glaucoma surgery.We show that the
availability of reliable and global data on the rates of glauco-
ma surgery is an unmet need. Results form the current study
should raise awareness on the part of all stakeholders in the
field of glaucoma that the scarcity of data should be addressed.
The World Glaucoma Association and other supranational
bodies are best placed to coordinate data collection on glau-
coma surgical rates and provide technical expertise whenever
requested. These data would be a key input that affects
decision-making about how to allocate increasingly scarce
health care resources. They could further encourage profes-
sional groups and the ophthalmic industry to make glaucoma
surgery affordable for underprivileged populations.
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